Skip to main content
. 2023 Mar 2;15(3):820. doi: 10.3390/pharmaceutics15030820

Figure 8.

Figure 8

(A) Blood glucose level vs. time profiles of the diabetic rats following the administration of different formulations (X ± SD, n = 6). (B) Serum insulin level vs. time profiles of diabetic rats following the administration of different formulations (X ± SD, n = 6). (C) Relative bioavailability (X ± SD, n = 6, *** p < 0.001).